This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 01/27/2022
Location: Virtual
Subject: FDA's Patient Engagement Collaborative
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, and other invited guests

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 01/24/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; DONALD PRATER;
Non FDA Participant/Group: Harold Chase (NSF International and Partnership for Food Safety Education); Britanny Saunier, Stephanie Darilus (Partnership for Food Safety Education); Michael Roberson (Publix Super Markets and Partnership for Food Safety Education);

Event Date: 01/26/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: CHARLOTTE CHRISTIN; CAITLIN BOON; LARRY MORRIS; SUZANNE ROOSEN;
Non FDA Participant/Group: Michael Gruber, Roberta Wagner, Spencer Pederson (Consumer Brands Association);

Event Date: 01/28/2022
Location: Virtual
Subject: FDA Foods Program Overview
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Pam Miller (House Appropriations Agriculture Sub-Committee);

Event Date: 01/28/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS;
Non FDA Participant/Group: Kathy Gramling, Ross Brubaker (Ernst & Young Global Limited);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 01/24/2022
Location: Virtual
Subject: Duke Margolis Center for Health Policy Endpoint Considerations to Facilitate Drug Development for Niemann-Pick Type C (NPC) Workshop
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 01/24/2022
Location: Virtual
Subject: MITRE Sentinel Interview for PDUFA VI Assessment
FDA Participant/Group: N/A
Non FDA Participant/Group: Patricia Carter, Stuart Williams (MITRE Corporation);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/24/2022
Location: Virtual
Subject: Non-Trial Preapproval Access In A Pandemic: The Good, Bad, and Unanticipated
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the New York University Grossman School of Medicine’s Compassionate Use and Preapproval Access Virtual Conference

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 01/28/2022
Location: Virtual
Subject: Medtronic’s Patient Safety & Quality Improvement Plan
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several Medtronic staff

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event